News Conference News TVT 2023 Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI Shelley Wood June 14, 2023
News Conference News TVT 2023 Latest-Generation MitraClip Devices Make Strides Against Residual MR Shelley Wood June 09, 2023
News Conference News TVT 2023 Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years Michael O'Riordan June 09, 2023
News Conference News TVT 2022 Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry Michael O'Riordan June 13, 2022
News Conference News TVT 2022 Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests Michael O'Riordan June 09, 2022
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
News Conference News TVT 2021 Timing of Mitral Surgery After Failed TEER Influences Outcomes Todd Neale July 21, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News TVT 2020 Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes L.A. McKeown June 19, 2020
News Conference News TVT 2019 Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery Michael O'Riordan June 20, 2019
News Conference News TVT 2019 Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results Shelley Wood June 19, 2019
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
News Conference News TVT 2017 Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line Michael O'Riordan June 20, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017